| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |